Dr. Shiyanbola’s research examines patient perceptions in medication use and its impact on medication adherence, health literacy and the elimination of diabetes disparities. Specifically, Dr. Shiyanbola studies the perceptions of illness and medicines among marginalized populations. She interweaves patient perspectives into the development of tailored patient-centered medication use interventions. In her other areas of interests, Dr. Shiyanbola uses health literacy principles to empirically redesign health information documents to improve patient understanding and medication safety. She utilizes socio-behavioral and health psychology theories in her studies and employs qualitative, quantitative, and mixed methods approaches in her work. Dr. Shiyanbola was a NIH Mixed Methods Research Training Program Scholar, a National Institute of Minority Health and Health Disparities Research Institute Scholar, and a NHLBI/OBSSR Behavioral Clinical Trial Fellow. She had a NIH/ICTR KL2 Career Development Award and is currently funded by NIH/NIDDK, AHRQ, ICTR and other funders to develop and implement psychosocial and behavioral interventions to improve self-management in patients with diabetes and other related chronic conditions. Dr. Shiyanbola is  co-chair of the Society of Behavioral Medicine Health Equity Awards committee and an appointed member of the National Academies of Science, Engineering, and Medicine Roundtable on Health Literacy. 

Dr. Shiyanbola is an Associate Professor in the Social and Administrative Sciences Division in the School of Pharmacy. She received her Pharmacy degree  (B.Pharm) from the University of Ibadan in Nigeria and her Ph.D. in Pharmaceutical Socioeconomics from the University of Iowa in Iowa City. For her PhD degree, Dr. Shiyanbola examined beliefs in medicines, changes in beliefs overtime and its impact on patient health outcomes. Before joining the University of Wisconsin School of Pharmacy faculty in 2013, Dr. Shiyanbola was a faculty at South Dakota State University College of Pharmacy. In the PharmD curriculum, Dr. Shiyanbola teaches on the Social and Behavioral Aspects of Pharmacy Practice, Psychosocial Aspects of Medication Use and the Role of the Pharmacist in the Public Health System. In the Health Services Research in Pharmacy Graduate Program, she teaches the design, approach, and use of mixed methods for PhD Pharmacy and Health Science Students.

Education:

• PhD 2009 Pharm Socioeconomics - University of Iowa
• BPharm 2002 Pharmacy - University of Ibadan, Nigeria

Research Summary: Utilizing Patient Perspectives to Improve Diabetes and Related Chronic Disease Medication Use, Health Literacy, and Health Equity.

PHM 414: Social and Behavioral Aspects of Pharmacy Practice

PHM 702: Mixed Methods for the Health Sciences: Design, Purpose and Approach

(Since 2017)

• Abrams L, Look K, Shiyanbola OO. A Quantitative Analysis of the Association Between Chronic Illness, Patient-Provider Communication, and Patient BMI. Health Communication. 1-8. https://doi.org/10.1080/10410236.2023.2218606
• Rao D, Mercy M, McAtee C, Ford J, Shiyanbola OO. A scoping literature review of pharmacy-based opioid misuse screening and brief interventions. Research in Social and Administrative Pharmacy. 2023
• Rao D, Stevenson B, Shiyanbola OO. Using the Integrated Theory of Health Behavior Change to Assess Factors Affecting Diabetes Medication Adherence among African Americans during COVID-19: An explanatory sequential mixed methods design. Ethnicity and Health. (2023) 1-23, https://doi.org/10.1080/13557858.2023.2198683
• Tarfa A, Nordin J, Mott M, Maurer M, Shiyanbola OO. A qualitative exploration of the experiences of peer leaders in an intervention to improve diabetes medication adherence in African Americans. BMC Public Health (2023) 23 (1), 1-11.
• Shiyanbola OO, Maurer M, Wen MJ. Protocol for A Pilot Randomized Controlled Mixed Methods Feasibility Trial to Examine the Benefits of a Culturally Adapted Peer Support and Self-Management Intervention to Improve Glycemic Control in African Americans. Pharmacy2023, 11(1), 2; https://doi.org/10.3390/pharmacy11010002
• Tarfa A, Pecanac K, Shiyanbola OO. A Qualitative Inquiry into the Barriers to Linkage and Retention in HIV Care within the Community Setting. Exploratory Research in Clinical and Social Pharmacy, 2022, (in press) https://doi.org/10.1016/j.rcsop.2022.100207.
• Shiyanbola OO, Maurer M, Mott M, Schwerer L, Sarkarati N, Ward E, Sharp L. A feasibility pilot trial of a peer-supported intervention to address psychosocial and sociocultural factors in diabetes medication adherence among African Americans. Pilot and Feasibility Studies. 8, 240 (2022). https://doi.org/10.1186/s40814-022-01198-7.
• Shiyanbola OO, Maurer M, Schwerer L, Sarkarati N, Wen M, Salihu E, Nordin J, Xiong P, Egbujor U, Williams S. A culturally tailored diabetes self-management intervention integrating race-congruent peer support to address beliefs, medication adherence and diabetes control in African Americans: a pilot feasibility study. Patient Preference and Adherence, 2022, 16: 2893-2912.
• Wen M, Maurer M, Schwerer L, Sarkarati N, Egbujor U, Nordin J, Williams S, Liu Y, Shiyanbola OO. Perspectives on a Novel Culturally Tailored Diabetes Self-Management Program for African Americans: A Qualitative Study of Healthcare Professionals and Organizational Leaders. International Journal of Environmental Research and Public Health. 2022, 19 (19), 12814, https://doi.org/10.3390/ijerph191912814
• Tarfa A, Nordin J, Mattigan M, Maurer M, Shiyanbola OO. A qualitative exploration of the experiences of peer leaders in an intervention to improve diabetes medication adherence in African Americans, 29 September 2022, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-1991315/v1] 
• Tidd M, Shiyanbola OO, Ford J, Richert L. Developing, Revising, and Assessing the Use of an Infographic on Pre-exposure Prophylaxis (PrEP) for Community Pharmacists. Journal of the American Pharmacist Association. 2022. https://doi.org/10.1016/j.japh.2022.07.010
• Shiyanbola OO, Rao D, Kuehl S, Bolt D, Ward E, Brown C. Psychometric Evaluation of a Culturally Adapted Illness Perception Questionnaire for African Americans with Type 2 Diabetes. BMC Public Health. 2022, 741, 1-15. 2022. https://doi.org/10.1186/s12889-022-13172-2
• Bader M, Zheng L, Rao D, Shiyanbola OO, Myers L, Davis T, O’Leary C, McKee M, Wolf M, Assaf A. Towards a more patient-centered clinical trial process: a systematic review of interventions incorporating health literacy best practices. Contemp Clin Trials. 2022 Mar 14:106733. doi: 10.1016/j.cct.2022.106733.
• Shiyanbola OO, Maurer M, Viruetta N, Pigarelli D, Huang YM, Unni E, Smith P. Feasibility of a randomized controlled mixed method trial to address health literacy, beliefs, medication adherence, and self-efficacy in a clinical pharmacist-led clinic. Patient Prefer Adherence. 2022; 16:679-696 https://doi.org/10.2147/PPA.S349258.
• Maurer M, Shiyanbola OO, Mott M, Means J. Engaging patient advisory boards of African American community members with type 2 diabetes in implementing and refining a peer-led medication adherence intervention. Pharmacy. 2022; 10(2):37. https://doi.org/10.3390/pharmacy10020037. Special issue - Medicine use in Chronic Disease.
• Tarfa A, Pecanac K, Shiyanbola OO. Patients, Social workers, and Pharmacists’ Perceptions of Barriers to Providing HIV Care in Community Pharmacies. Pharmacy2021, 9(4), 178; https://doi.org/10.3390/pharmacy9040178
• Shiyanbola OO, Maurer M, Mott M, et al. A Feasibility Pilot Trial of a Peer-support Educational Behavioral Intervention to Improve Diabetes Medication Adherence in African Americans, 22 November 2021, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-1072559/v1] 
• Shiyanbola OO, Rao, D Kuehl S, Bolt D, Brown C, Ward E. Psychometric Evaluation of a Culturally Adapted Illness Perception Questionnaire for African Americans with Type 2 Diabetes, 13 September 2021, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-812773/v1] 
• Huang Y, Shiyanbola OO. Investigation of the Barriers and Facilitators to Medication Adherence in Patients with Type 2 Diabetes across Different Health Literacy Levels: An Explanatory Sequential Mixed Methods Study. Pharmacol. 12:745749. 2021. doi: 10.3389/fphar.2021.745749
• Shiyanbola OO, Rao D, Bolt D, Zhang M, Brown C, Ward E. Using an Exploratory Sequential Mixed Methods Design to Develop a Culturally Adapted Illness Perception Questionnaire for African Americans with Diabetes: The Data Integration Process. Health Psychology and Behavioral Medicine. 9:1, 796-817. DOI: 10.1080/21642850.2021.1976650.
• Rao D, Meyer J, Maurer M, Shiyanbola OO. Perceptions of Psychosocial and Interpersonal Factors Affecting Self-Management Behaviors among African Americans with Diabetes. Exploratory Research in Clinical and Social Pharmacy 2021. https://doi.org/10.1016/j.rcsop.2021.100057
• Rao D, Shiyanbola OO. Best Practices for Conducting and Writing Mixed Methods Research in Pharmacy. Research in Social and Administrative Pharmacy 2021 doi:10.1016/j.sapharm.2021.04.015
• Mafruhah OR, Huang YM, Shiyanbola OO, Shen GL, Lin HW. Ideal instruments used to measure health literacy related to medication use: a systematic review. Research in Social and Administrative Pharmacy 2021 doi: 10.1016/j.sapharm.2021.01.017 (in press)
• Shiyanbola OO, Kaiser B, Thomas G, Tarfa A. Preliminary Engagement of a Patient Advisory Board of African Americans with Type 2 Diabetes in a Peer-Led Diabetes Medication Adherence Intervention. Research Involvement and Engagement. 2021 Jan 6;7(1):4. doi: 10.1186/s40900-020-00245-y.
• Shiyanbola OO, Huang YM. Reducing the rates of diabetes across the United States. APhA–APRS. Studies show benefit of pharmacists’ integration into diabetes prevention programs. Journal of the American Pharmacist Association, 2020. 60 (6), 767-769
• Huang Y, Pecanac K, Shiyanbola OO. “Why am I not taking medications?”: barriers and facilitators of diabetes medication adherence across different health literacy levels. Qual Health Res.2020; 30 (14) 2331-2342. doi:10.1177/1049732320945296
• Shiyanbola OO, Maurer M, Ward E, Sharp L, Lee J, Tarfa A. Protocol for Partnering with Peers Intervention to Improve Medication Adherence among African Americans with Type 2 Diabetes. medRxiv: 2020.2006.2004.20122895
• Huang Y, Shiyanbola OO, Hsun-Yu Chan, Smith P. What specific patient factors associated with diabetes medication adherence differ across various health literacy levels? Post Graduate Medicine. 2020. 1-9. https://doi.org/10.1080/00325481.2020.1749499
• Rao D, Maurer M, Meyer J, Zhang J, Shiyanbola OO. Medication Adherence Changes in Blacks with Diabetes: A Mixed Methods Study. American Journal of Health Behavior 2020; 44 (2): 257-270.  DOI: https://doi.org/10.5993/AJHB.44.2.13
• Shiyanbola OO, Tarfa A, Song A, Sharp L, Ward E. Preliminary Testing of a Peer-Supported Diabetes Medication Adherence Intervention for African-Americans. Health Behavior and Policy Review 2019; 6 (6) 558-569. DOI: https://doi.org/10.14485/HBPR.6.6.2.
• Shiyanbola OO, Bolt D, Tarfa A, Brown C, Ward E. A Content Validity and Cognitive Interview Process to Evaluate an Illness Perception Questionnaire for African Americans with Type 2 diabetes, BMC Research Notes 2019. 12:308. https://doi.org/10.1186/s13104-019-4342-9
• Shiyanbola OO, Pigarelli D, Unni E, Smith PD, Maurer M, Huang Y. Design and rationale of a mixed methods randomized control trial: ADdressing Health literacy, bEliefs, adheRence and self-Efficacy (ADHERE) program to improve diabetes outcomes. Contemporary Clinical Trials Communications 2019. Available online January 14 2019 https://doi.org/10.1016/j.conctc.2019.100326 
• Unni E, Wagoner E, Shiyanbola OO. Utilizing a 3S (Strategies, Source and Setting) approach to understand the patient’s preference when addressing medication non-adherence in patients with diabetes: a focus group study in a primary outpatient clinic. BMJ Open 2019; 9: e024789. http:// doi: 10.1136/bmjopen-2018-024789. 
• Shiyanbola OO, Unni E, Huang Y, Lanier C. Utilizing the Extended Self-Regulatory Model to Characterize Medication Adherence: A Cross-sectional Study. BMJ Open, 2018;8:e022803. doi:10.1136/ bmjopen-2018-022803
• Shiyanbola OO, Ward E, Brown C. Utilizing the Common Sense Model to explore African American Patients’ Perception of Type 2 Diabetes. PLOS One, 2018, 13(11): e0207692. https://doi.org/10.1371/journal. pone.0207692
• Liu Y, Zupan N, Shiyanbola OO, Swearingen R, Carlson J, Jacobson N, Mahoney J, Klein R, Bjelland T, Smith M. Factors Influencing Patient Adherence with Diabetic Eye Screening in Rural Communities: A Qualitative Study. PLOS One, 2018, 13(11):e0206742 https://doi.org/10.1371/journal.pone.0206742
• Bhuyan SS, Shiyanbola OO, Kedia S, Chandak A, Wang Y, Isehunwa O, Anunobi N, Ebuenyi I, Deka P, Ahn S, Chang C. The Role of Gender in Cost-Related Medication non-adherence among Patients with Diabetes. Journal of the American Board of Family Medicine. 2018; 31:743-751; doi:10.3122/jabfm.2018.05.180039.
• Huang Y, Shiyanbola OO, Hsun-Yu Chan. A Path Model Linking Health Literacy, Self-efficacy, Medication Adherence, and Glycemic Control. Patient Education and Counseling 2018, 101;11: 1906-1913. DOI: https://doi.org/10.1016/j.pec.2018.06.010
• Huang Y, Shiyanbola OO, Smith P, Hsun-Yu Chan. Quick screen of patient’s numeracy and document literacy skills: the factor structure of the Newest Vital Sign. Patient Preference and Adherence 2018; 12: 853- 859. doi: 10.2147/PPA.S165994
• Huang Y, Shiyanbola OO, Smith P. The Association of Health Literacy and Medication Self-efficacy with Medication Adherence and Diabetes Control. Patient Preference and Adherence 2018; 12: 793-802. doi: 10.2147/PPA.S153312
• Shiyanbola OO, Brown C, Ward E. “I did not want to take that medicine”: African Americans reasons for diabetes medication nonadherence and perceived solutions for enhancing adherence. Patient Preference and Adherence 2018; 12: 409-421
• Shiyanbola OO, Ward E, Brown C. Sociocultural Influences on African Americans Representations of Type 2 Diabetes: A Qualitative Study. Ethn Dis. 2018;28(1):25-32; doi:10.18865/ed.28.1.25. 31. 
• Shiyanbola OO, Unni E, Huang Y, Lanier C. The Association of Health Literacy with Illness Perceptions, Medication Beliefs, and Medication Adherence among Individuals with Type 2 Diabetes. Research in Social and Administrative Pharmacy 2018; 14 (9), 824-830. DOI: http://dx.doi.org/10.1016/j.sapharm.2017.12.005
• Goetsch NJ, Hoehns JD, Sutherland JE, Ulven, ME, Shiyanbola OO, Rauch MK. Assessment of Postgraduate Skin Lesion Education Among Iowa Family Physicians. SAGE Open Medicine 2017, 4, 1-7 DOI: 10.1177/2050312117691392
• Shiyanbola OO, Smith P, Huang Y, Ghura S. Pharmacist and Patient Feedback on Empirically-Designed Prescription Warning Labels: A Qualitative Study. International Journal of Clinical Pharmacy Jan 9, 2017 doi: 10.1007/s11096-016-0421-3. [Epub ahead of print]
• Bhuyan SS, Shiyanbola OO, Kedia S, Chandak A, Wang Y, Isehunwa O, Anunobi N, Ebuenyi I, Deka P, Ahn S, Chang C. Does Cost-Related Medication Nonadherence among Cardiovascular Disease Patients Vary by Gender? Evidence from a Nationally Representative Sample. Women’s Health Issues Jan/Feb 2017, 27 (1), 108-115